Century Capital Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.01M Sell
38,638
-1,848
-5% -$45.4K 0.17% 165
2017
Q1
$947K Sell
40,486
-9,304
-19% -$230K 0.15% 178
2016
Q4
$1.25M Sell
49,790
-4,757
-9% -$120K 0.16% 175
2016
Q3
$1.53M Sell
54,547
-128,453
-70% -$3.29M 0.19% 172
2016
Q2
$4.51M Buy
183,000
+28,354
+18% +$704K 0.5% 94
2016
Q1
$3.42M Sell
154,646
-698,822
-82% -$18.6M 0.38% 128
2015
Q4
$29.9M Sell
853,468
-163,837
-16% -$5.13M 1.71% 6
2015
Q3
$29M Buy
1,017,305
+119,647
+13% +$4.02M 1.64% 4
2015
Q2
$29.9M Sell
897,658
-29,684
-3% -$911K 1.69% 9
2015
Q1
$26.1M Buy
927,342
+96,504
+12% +$2.4M 1.5% 18
2014
Q4
$17.2M Buy
830,838
+238,778
+40% +$5.67M 0.99% 37
2014
Q3
$14.5M Hold
592,060
0.85% 44
2014
Q2
$16.9M Buy
592,060
+263,918
+80% +$7.34M 0.89% 47
2014
Q1
$9.18M Buy
+328,142
New +$8.06M 0.43% 75

Other funds holding PMC

Century Capital Management's PMC Position: Q2 2017 in Review

Century Capital Management reduced its PharMerica Corporation (PMC) stake by 4.6% in Q2 2017, selling an estimated $45.4K and leaving 38,638 shares worth $1.01M. The position accounts for 0.17% of the portfolio, ranked #165.

Century Capital Management first reported a position in PMC in Q1 2014 and has held it in 14 quarters since. The position peaked at $29.9M in Q2 2015. 157 funds tracked by Wall St. Rank hold PMC as of Q2 2017.

  • Century Capital Management held 38,638 shares of PharMerica Corporation worth $1.01M as of Q2 2017.
  • Century Capital Management sold 1,848 PharMerica Corporation shares in Q2 2017, an estimated $45.4K.
  • PharMerica Corporation made up 0.17% of Century Capital Management's portfolio in Q2 2017, its #165 holding.
  • Century Capital Management first reported a position in PharMerica Corporation in Q1 2014 and has held it in 14 quarters since.
  • Century Capital Management's PharMerica Corporation position peaked at $29.9M in Q2 2015.
  • 157 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2017.

Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.